Headlines

Additional European Equity News - 24th August 2026

Newsquawk Staff ·

Evolution (EVOL SS) - Co. has acquired a total of 895,687 own shares within the framework of the repurchase program. (Evolution)

GSK (GSK LN) - Japan approves Hibsago for chronic hepatitis B, marking its first global approval.

Metso (METSO FH) - Co. enhances its slurry pumps portfolio with acquisition of hose and progressive cavity pumps business. (Metso)

Related headlines